- Home
- CODX vs ICU Comparison
CODX vs ICU Comparison
Compare CODX & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- ICU
- Stock Information
- Founded
- CODX 2013
- ICU 2018
- Country
- CODX United States
- ICU United States
- Employees
- CODX N/A
- ICU N/A
- Industry
- CODX Medical/Dental Instruments
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- CODX Health Care
- ICU Health Care
- Exchange
- CODX Nasdaq
- ICU Nasdaq
- Market Cap
- CODX 11.9M
- ICU 10.4M
- IPO Year
- CODX 2017
- ICU N/A
- Fundamental
- Price
- CODX $0.26
- ICU $1.18
- Analyst Decision
- CODX Buy
- ICU
- Analyst Count
- CODX 2
- ICU 0
- Target Price
- CODX $5.50
- ICU N/A
- AVG Volume (30 Days)
- CODX 606.2K
- ICU 144.0K
- Earning Date
- CODX 05-08-2025
- ICU 05-14-2025
- Dividend Yield
- CODX N/A
- ICU N/A
- EPS Growth
- CODX N/A
- ICU N/A
- EPS
- CODX N/A
- ICU N/A
- Revenue
- CODX $3,497,583.00
- ICU $428,000.00
- Revenue This Year
- CODX N/A
- ICU $648.15
- Revenue Next Year
- CODX $42.11
- ICU $100.00
- P/E Ratio
- CODX N/A
- ICU N/A
- Revenue Growth
- CODX N/A
- ICU N/A
- 52 Week Low
- CODX $0.23
- ICU $1.11
- 52 Week High
- CODX $2.23
- ICU $13.85
- Technical
- Relative Strength Index (RSI)
- CODX 38.53
- ICU 35.77
- Support Level
- CODX $0.23
- ICU $1.13
- Resistance Level
- CODX $0.34
- ICU $1.34
- Average True Range (ATR)
- CODX 0.06
- ICU 0.07
- MACD
- CODX -0.00
- ICU 0.00
- Stochastic Oscillator
- CODX 12.21
- ICU 23.81
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.